Canadians pay very high prices for generic drugs compared to international norms. The reason is not inefficient or noncompetitive generic drug companies, but provincial government pricing and insurance policies that are distorting the market. This paper by Professor Aidan Hollis, an expert in...

Led by the pharmaceutical manufacturing industry, IP-intensive manufacturing industries contribute extraordinary economic value to the U.S. economy. Compared to other IP-intensive and non-IP intensive manufacturing industries, the pharmaceutical manufacturing industry had the highest R&D...

We estimated the average returns, in terms of patient survival, to the marginal innovations in oral chemotherapy market induced by Part D expansion of oral chemotherapy coverage for elderly individuals by mandating inclusion of “all or substantially all” oral anti-cancer medications on...

Umbrella branding is a marketing practice whereby multi-product firms leverage their reputation across different product categories. This paper investigates how advertising in the market of over-the-counter (OTC) drugs affects the decision to buy prescription drugs from a promoted brand name. I...

Mental illnesses are prevalent in the United States and globally. Cost is a critical barrier to treatment receipt. We study the effects of recent and major eligibility expansions within Medicaid, a public insurance system for the poor in the U.S., on psychotropic prescription medications for...

Looking at how well drugs work in routine clinical practice, rather than only in experimental randomised controlled clinical trials (RCTs), is increasingly seen as essential for a proper assessment of both net benefit (health gain minus harm and value (net benefit minus net cost). Establishing...

Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...

We derive equilibrium incentives to use comparative advertising that pushes up own brand perception and pulls down the brand image of targeted rivals. Data on content and spending for all TV advertisements in OTC analgesics enable us to construct matrices of dollar rival targeting and estimate...

In recent years, the increased use of “big data” and statistical techniques to score potential transactions has transformed the operation of insurance and credit markets. In this paper, we observe that these widely-used scores are statistical objects that constitute a one-dimensional summary...